1o7s › Citations

High resolution crystal structures of Siglec-7. Insights into ligand specificity in the Siglec family.

Alphey MS, Attrill H, Crocker PR, van Aalten DM
J Biol Chem 278 3372-7 (2003)
Cited: 68 times
EuropePMC logo PMID: 12438315

Abstract

Sialic acid-binding immunoglobulin-like lectins (Siglecs) recognize sialylated glycoconjugates and play a role in cell-cell recognition. Siglec-7 is expressed on natural killer cells and displays unique ligand binding properties different from other members of the Siglec family. Here we describe the high resolution structures of the N-terminal V-set Ig-like domain of Siglec-7 in two crystal forms, at 1.75 and 1.9 A. The latter crystal form reveals the full structure of this domain and allows us to speculate on the differential ligand binding properties displayed by members of the Siglec family. A fully ordered N-linked glycan is observed, tethered by tight interactions with symmetry-related protein molecules in the crystal. Comparison of the structure with that of sialoadhesin and a model of Siglec-9 shows that the unique preference of Siglec-7 for alpha(2,8)-linked disialic acid is likely to reside in the C-C' loop, which is variable in the Siglec family. In the Siglec-7 structure, the ligand-binding pocket is occupied by a loop of a symmetry-related molecule, mimicking the interactions with sialic acid.

Reviews - 1o7s mentioned but not cited (2)

  1. Current Status on Therapeutic Molecules Targeting Siglec Receptors. Lenza MP, Atxabal U, Oyenarte I, Jiménez-Barbero J, Ereño-Orbea J. Cells 9 E2691 (2020)
  2. Sialic Acids and Their Influence on Human NK Cell Function. Rosenstock P, Kaufmann T. Cells 10 263 (2021)

Articles - 1o7s mentioned but not cited (4)



Reviews citing this publication (19)

  1. Siglecs and their roles in the immune system. Crocker PR, Paulson JC, Varki A. Nat Rev Immunol 7 255-266 (2007)
  2. Siglecs--the major subfamily of I-type lectins. Varki A, Angata T. Glycobiology 16 1R-27R (2006)
  3. Siglecs and immune regulation. Pillai S, Netravali IA, Cariappa A, Mattoo H. Annu Rev Immunol 30 357-392 (2012)
  4. Immunological Effects of Human Milk Oligosaccharides. Triantis V, Bode L, van Neerven RJJ. Front Pediatr 6 190 (2018)
  5. Disulfide bonding in protein biophysics. Fass D. Annu Rev Biophys 41 63-79 (2012)
  6. Sialic acid-binding immunoglobulin-like lectins (Siglecs) detect self-associated molecular patterns to regulate immune responses. Läubli H, Varki A. Cell Mol Life Sci 77 593-605 (2020)
  7. Sampling and signaling in plasmacytoid dendritic cells: the potential roles of Siglec-H. Blasius AL, Colonna M. Trends Immunol 27 255-260 (2006)
  8. Human natural killer cell receptors: insights into their molecular function and structure. Biassoni R, Cantoni C, Marras D, Giron-Michel J, Falco M, Moretta L, Dimasi N. J Cell Mol Med 7 376-387 (2003)
  9. Sugar Free: Novel Immunotherapeutic Approaches Targeting Siglecs and Sialic Acids to Enhance Natural Killer Cell Cytotoxicity Against Cancer. Daly J, Carlsten M, O'Dwyer M. Front Immunol 10 1047 (2019)
  10. Inhibitory Receptors and Checkpoints in Human NK Cells, Implications for the Immunotherapy of Cancer. Sivori S, Della Chiesa M, Carlomagno S, Quatrini L, Munari E, Vacca P, Tumino N, Mariotti FR, Mingari MC, Pende D, Moretta L. Front Immunol 11 2156 (2020)
  11. Natural Killer Cells: Tumor Surveillance and Signaling. Meza Guzman LG, Keating N, Nicholson SE. Cancers (Basel) 12 E952 (2020)
  12. Molecular diversity and evolution of the Siglec family of cell-surface lectins. Angata T. Mol Divers 10 555-566 (2006)
  13. The Roles of Siglec7 and Siglec9 on Natural Killer Cells in Virus Infection and Tumour Progression. Zheng Y, Ma X, Su D, Zhang Y, Yu L, Jiang F, Zhou X, Feng Y, Ma F. J Immunol Res 2020 6243819 (2020)
  14. A Structural Perspective on Calprotectin as a Ligand of Receptors Mediating Inflammation and Potential Drug Target. Garcia V, Perera YR, Chazin WJ. Biomolecules 12 519 (2022)
  15. Molecular Recognition Insights of Sialic Acid Glycans by Distinct Receptors Unveiled by NMR and Molecular Modeling. Soares CO, Grosso AS, Ereño-Orbea J, Coelho H, Marcelo F. Front Mol Biosci 8 727847 (2021)
  16. Multivalent Sialosides: A Tool to Explore the Role of Sialic Acids in Biological Processes. Chaudhary PM, Toraskar S, Yadav R, Hande A, Yellin RA, Kikkeri R. Chem Asian J 14 1344-1355 (2019)
  17. Sialylation: A Cloak for Tumors to Trick the Immune System in the Microenvironment. Zhou X, Chi K, Zhang C, Liu Q, Yang G. Biology (Basel) 12 832 (2023)
  18. Glycomimetic Peptides as Therapeutic Tools. Hoober JK, Eggink LL. Pharmaceutics 15 688 (2023)
  19. Targeting Siglec-Sialylated MUC1 Immune Axis in Cancer. Ayyalasomayajula R, Cudic M. Cancers (Basel) 16 1334 (2024)

Articles citing this publication (43)



Quick links